Is an intravenous fluid bolus of albumin or normal saline beneficial in the treatment of metabolic acidosis in a normovolaemic newborn?
Author:
Open Access
- 1 September 2004
- journal article
- review article
- Published by BMJ in Archives of Disease in Childhood
- Vol. 89 (9) , 884-885
Abstract
In the absence of asphyxia or hypovolaemia in a newborn infant with metabolic acidosis [patient] does an intravenous bolus of normal saline or albumin [intervention] improve the following [outcomes]: pH, base deficit, mortality, morbidity, length of hospital stay, neurodevelopmental disability?Keywords
This publication has 16 references indexed in Scilit:
- Endomysium antibodies in the diagnosis of celiac disease in short‐statured children with no gastrointestinal symptomsPediatrics International, 2001
- Does the Structure of Clinical Questions Affect the Outcome of Curbside Consultations With Specialty Colleagues?Archives of Family Medicine, 2000
- An iceberg of childhood coeliac disease in the NetherlandsThe Lancet, 1999
- Celiac disease in Turkish short‐statured children and the value of antigliadin antibody in diagnosisPediatrics International, 1998
- Evaluation of a district growth screening programme: the Oxford Growth Study.Archives of Disease in Childhood, 1993
- Incidence of celiac disease identified by the presence of serum endomysial antibodies in children with chronic diarrhea, short stature, or insulin-dependent diabetes mellitusThe Journal of Pediatrics, 1993
- Poor growth in school entrants as an index of organic disease: the Wessex growth study.BMJ, 1992
- Short stature due to unrecognized celiac diseaseEuropean Journal of Pediatrics, 1988
- Coeliac disease in children of short stature without gastrointestinal symptomsEuropean Journal of Pediatrics, 1986
- Short Stature as the Major Manifestation of Celiac Disease in Older ChildrenClinical Pediatrics, 1986